King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Ali AlAhmari
Dr. Ali AlAhmari is a Professor and Consultant in Paediatric Haematology/Oncology and Section Head of Paediatric Stem Cell Transplantation (SCT) and Cellular Therapy, with specialist expertise in haematopoietic stem cell transplantation for children with thalassaemia, sickle cell disease, and primary immunodeficiencies — a leading paediatric haematologist oncologist in Riyadh, Saudi Arabia for international families seeking advanced paediatric bone marrow transplant care. He founded and directs a Paediatric CAR-T Cell Therapy Program and a Histiocytosis Program.
- Professor & Section Head of Paediatric Stem Cell Transplantation and Cellular Therapy
- Founder & Director, Paediatric CAR-T Cell Therapy Program — first-in-region for paediatric patients
- Director, Paediatric Histiocytosis Program — regional referral centre for Langerhans Cell Histiocytosis
- Invited speaker at SIOP Asia 2025 on paediatric haematopoietic stem cell transplantation
- Published researcher on paediatric thalassaemia HSCT, sickle cell HSCT, and hyper-IgM syndrome transplantation
Qualifications & Credentials
Medical Degrees
- MBBS — Bachelor of Medicine and Bachelor of Surgery
- Paediatric Residency
Fellowships & Special Training
- Fellowship in Paediatric Haematology/Oncology
- Fellowship in Paediatric Stem Cell Transplantation and Cellular Therapy
- Advanced Training in Paediatric CAR-T and Cellular Immunotherapy
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) — Registered Consultant
- European Society for Blood and Marrow Transplantation (EBMT) — Member
- American Society of Hematology (ASH) — Member
Areas of Expertise
Major Conditions Treated
- Paediatric Acute Lymphoblastic Leukaemia (ALL)
- Paediatric Acute Myeloid Leukaemia (AML)
- Beta-Thalassaemia Major
- Sickle Cell Disease
- Severe Combined Immunodeficiency (SCID)
- Hyper-IgM Syndrome
- Fanconi Anaemia
- Langerhans Cell Histiocytosis (LCH)
- Haemophagocytic Lymphohistiocytosis (HLH)
- Aplastic Anaemia
- Paediatric Lymphoma (Hodgkin and Non-Hodgkin)
Sub-specialties
- Paediatric Stem Cell Transplantation: Matched related, unrelated, and haploidentical HSCT for paediatric haematological malignancies, haemoglobinopathies, and primary immunodeficiencies — the region's leading paediatric BMT specialist for international families.
- Paediatric CAR-T Cell Therapy: CD19-directed CAR-T therapy for paediatric relapsed/refractory B-ALL and lymphoma, as founder-director of a first-in-region paediatric CAR-T programme.
- Paediatric Histiocytosis & Rare Disorders: Comprehensive management of Langerhans Cell Histiocytosis, HLH, and rare paediatric histiocytic disorders — a designated regional referral centre.
Advanced Procedures & Treatments
- Matched-Related Donor HSCT (MRD-HSCT)
- Matched-Unrelated Donor HSCT (MUD-HSCT)
- Haploidentical Stem Cell Transplantation
- CD19 CAR-T Cell Therapy (Paediatric Protocols)
- Reduced-Intensity Conditioning (RIC) Transplant
- Gene Therapy Coordination for Haemoglobinopathies
- Post-Transplant Cyclophosphamide Protocols
- Graft-versus-Host Disease (GvHD) Management
Professional Experience
Current Affiliation
- Professor & Consultant, Paediatric Haematology/Oncology — King Fahad National Centre for Children's Cancer & Research (KFNCCC&R), King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia (Present)
- Section Head, Paediatric Stem Cell Transplantation & Cellular Therapy — KFSHRC, Riyadh (Present)
- Founder & Director, Paediatric CAR-T Cell Therapy Program — KFSHRC, Riyadh (Present)
- Director, Paediatric Histiocytosis Program — KFSHRC, Riyadh (Present)
Past Affiliations
- Fellowship training in Paediatric Haematology/Oncology and Paediatric Stem Cell Transplantation (international fellowships completed prior to KFSHRC consultancy)
Academic & Research Roles
- Invited Faculty — SIOP Asia 2025 (Paediatric Stem Cell Transplantation)
- Faculty — Paediatric Haematology/Oncology training programmes at KFSHRC
- Peer reviewer for paediatric haematology/oncology journals
Key Achievements
- Performed hundreds of paediatric stem cell transplants across malignant and non-malignant indications
- Founded the first paediatric CAR-T cell therapy programme in Saudi Arabia
- Co-author on Al-Saud 2015 (Pediatric Transplantation) paediatric hyper-IgM HSCT outcomes
- Contributing author on Saudi paediatric thalassaemia and sickle cell transplantation outcome studies
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- European Society for Blood and Marrow Transplantation (EBMT)
- American Society of Hematology (ASH)
- International Society of Paediatric Oncology (SIOP)
- Saudi Society of Haematology
Research & Publications
Published Papers (Selected)
- Al-Saud B, AlAhmari A, et al. Haematopoietic Stem Cell Transplantation for Hyper-IgM Syndrome. Pediatric Transplantation. 2015.
- AlAhmari A, et al. Paediatric Haematopoietic Stem Cell Transplantation for Beta-Thalassaemia Major — Saudi Experience.
- AlAhmari A, et al. Haematopoietic Stem Cell Transplantation for Paediatric Sickle Cell Disease — Single Centre Outcomes.
- AlAhmari A. Paediatric Stem Cell Transplantation — SIOP Asia 2025 Invited Lecture.
Ongoing Research & Clinical Interests
- Paediatric CAR-T cell therapy in the Middle East
- Haploidentical HSCT in paediatric haemoglobinopathies
- Gene therapy for beta-thalassaemia and sickle cell disease
- Long-term outcomes of paediatric HSCT survivors
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Paediatric Oncology Consultation | ₹1,000 – ₹2,500 | $12 – $30 |
| Paediatric Chemotherapy (per cycle) | ₹25,000 – ₹1,75,000 | $300 – $2,100 |
| Paediatric Stem Cell Transplant | ₹18,00,000 – ₹35,00,000 | $21,700 – $42,200 |
| Tumour Biopsy & Molecular Profiling | ₹15,000 – ₹75,000 | $180 – $900 |
| Targeted / Immunotherapy (per cycle) | ₹80,000 – ₹3,00,000 | $960 – $3,600 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Ali AlAhmari use in Paediatric Haematology / Oncology — Stem Cell Transplantation treatment?
Dr. Ali AlAhmari uses advanced paediatric cellular therapy and transplant technologies including CD19 CAR-T cell therapy for paediatric B-ALL, haploidentical stem cell transplantation with post-transplant cyclophosphamide, reduced-intensity conditioning regimens for non-malignant disorders, matched-unrelated donor HSCT, and coordinated gene therapy protocols for beta-thalassaemia and sickle cell disease. Virtual consultations and remote second opinions are also available to international families through Cancer Rounds.
2. What conditions does Dr. Ali AlAhmari specialize in treating?
Dr. Ali AlAhmari specialises in Paediatric Haematology/Oncology and Stem Cell Transplantation, treating paediatric acute leukaemia (ALL/AML), beta-thalassaemia major, sickle cell disease, severe combined immunodeficiency (SCID), hyper-IgM syndrome, Fanconi anaemia, Langerhans cell histiocytosis, haemophagocytic lymphohistiocytosis (HLH), aplastic anaemia, and paediatric lymphomas. International families seeking the best paediatric bone marrow transplant doctor in India or Saudi Arabia benefit from his CAR-T and histiocytosis expertise.
3. How do I book an appointment with Dr. Ali AlAhmari?
Appointments with Dr. Ali AlAhmari can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Ali AlAhmari?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Ali AlAhmari, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Ali AlAhmari offer second opinions for Paediatric Haematology / Oncology — Stem Cell Transplantation cases?
Yes. Second opinion consultations for Paediatric Haematology/Oncology and transplant cases can be arranged via Cancer Rounds, connecting international families with Dr. Ali AlAhmari for remote review of paediatric transplant, CAR-T eligibility, and complex histiocytic disease cases.
